191 related articles for article (PubMed ID: 33247627)
1. Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction.
Cappetta D; De Angelis A; Flamini S; Cozzolino A; Bereshchenko O; Ronchetti S; Cianflone E; Gagliardi A; Ricci E; Rafaniello C; Rossi F; Riccardi C; Berrino L; Bruscoli S; Urbanek K
J Cell Mol Med; 2021 Jan; 25(1):217-228. PubMed ID: 33247627
[TBL] [Abstract][Full Text] [Related]
2. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
[TBL] [Abstract][Full Text] [Related]
3. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
[TBL] [Abstract][Full Text] [Related]
8. Apelin Is a Negative Regulator of Angiotensin II-Mediated Adverse Myocardial Remodeling and Dysfunction.
Zhang ZZ; Wang W; Jin HY; Chen X; Cheng YW; Xu YL; Song B; Penninger JM; Oudit GY; Zhong JC
Hypertension; 2017 Dec; 70(6):1165-1175. PubMed ID: 28974565
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
10. Ablation of lncRNA
Yang L; Deng J; Ma W; Qiao A; Xu S; Yu Y; Boriboun C; Kang X; Han D; Ernst P; Zhou L; Shi J; Zhang E; Li TS; Qiu H; Nakagawa S; Blackshaw S; Zhang J; Qin G
Theranostics; 2021; 11(16):7995-8007. PubMed ID: 34335976
[No Abstract] [Full Text] [Related]
11. Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.
Ingle KA; Kain V; Goel M; Prabhu SD; Young ME; Halade GV
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1827-36. PubMed ID: 26432841
[TBL] [Abstract][Full Text] [Related]
12. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.
Wang L; Zhang YL; Lin QY; Liu Y; Guan XM; Ma XL; Cao HJ; Liu Y; Bai J; Xia YL; Du J; Li HH
Eur Heart J; 2018 May; 39(20):1818-1831. PubMed ID: 29514257
[TBL] [Abstract][Full Text] [Related]
13. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin II-induced cardiac hypertrophy and vascular remodeling.
Kopaliani I; Jarzebska N; Billoff S; Kolouschek A; Martens-Lobenhoffer J; Bornstein SR; Bode-Böger SM; Ragavan VN; Weiss N; Mangoni AA; Deussen A; Rodionov RN
Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H825-H838. PubMed ID: 34533401
[TBL] [Abstract][Full Text] [Related]
15. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
[TBL] [Abstract][Full Text] [Related]
16. In vivo cardiac role of migfilin during experimental pressure overload.
Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
[TBL] [Abstract][Full Text] [Related]
18. TIGAR Deficiency Blunts Angiotensin-II-Induced Cardiac Hypertrophy in Mice.
He X; Williams QA; Cantrell AC; Besanson J; Zeng H; Chen JX
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397106
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
20. I-
Cao Y; Li L; Liu Y; Chen G; Tao Z; Wang R; Chen W
Oxid Med Cell Longev; 2021; 2021():6429197. PubMed ID: 33628362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
